AUS
NZ
UK
CA
USA
IND
Health
How Are Institutional Transactions Shaping Adaptive Biotechnologies (NASDAQ:ADPT)
February 14, 2025 09:28 AM PST| By Team Kalkine MediaHighlights,Adaptive Biotechnologies recorded a 7.9% stock increase after a revised price outlook.,Institutional investors hold 99.17% of the company's stock, reflecting active market participation.,Recent earnings reports showed financial performance...
Is Sage Therapeutics (NASDAQ:SAGE) Facing a Turning Point in the Market?
February 14, 2025 09:25 AM PST| By Team Kalkine MediaHighlights,Institutional investors have adjusted their holdings in Sage Therapeutics.,The company reported a negative net margin and return on equity.,Stock performance reflects fluctuations within the biopharmaceutical sector.,Institutional Investme...
How Is Perrigo Company plc (NYSE:PRGO) Navigating Institutional Adjustments and Market Shifts
February 14, 2025 09:22 AM PST| By Team Kalkine MediaHighlights,Institutional investors, including Wellington Management Group LLP and FMR LLC, modified their holdings in Perrigo.,Director Jeffrey B. Kindler sold 17,598 shares, reducing his position by 76.49%.,The stock opened at $24.80, trading within...
How Is Mineralys Therapeutics (NASDAQ:MLYS) Managing Market Adjustments and Institutional Transactions
February 14, 2025 09:22 AM PST| By Team Kalkine MediaHighlights,Mineralys Therapeutics' stock opened at $10.15, reflecting recent market adjustments.,Executive transactions included share sales by CEO Jon Congleton and CFO Adam Scott Levy.,Institutional investors, including Franklin Resources and Vangu...
How Is Axsome Therapeutics (NASDAQ:AXSM) Gaining Momentum with Institutional Support
February 14, 2025 09:20 AM PST| By Team Kalkine MediaHighlights,Financial institutions have adjusted their outlook on Axsome Therapeutics, revising expectations.,Institutional investors hold a significant portion of the company’s shares, reflecting increased market engagement.,Axsome Therapeutics conti...
How Is Medpace Holdings (NASDAQ:MEDP) Managing Institutional Shifts and Financial Growth
February 14, 2025 09:17 AM PST| By Team Kalkine MediaHighlights,Mirae Asset Global Investments Co. Ltd. reduced its stake in Medpace Holdings by 10.5%.,Institutional investors collectively control 77.98% of the company's outstanding shares.,Medpace reported earnings per share of $3.67, exceeding previo...
How Is Exact Sciences (NASDAQ:EXAS) Engaging Institutional Investors and Expanding Diagnostic Solutions
February 14, 2025 09:12 AM PST| By Team Kalkine MediaHighlights,Stratos Wealth Partners Ltd. acquired 3,969 shares of Exact Sciences valued at $223,000.,Institutional holdings in Exact Sciences have seen notable increases from multiple financial firms.,Exact Sciences continues to expand its cancer scre...
How Has Medtronic’s (NYSE:MDT) Strong Earnings Performance Affected Stock Activity
February 14, 2025 09:02 AM PST| By Team Kalkine MediaHighlights,Analysts provide mixed ratings for Medtronic with target price adjustments based on recent market activity.,Medtronic reports a year-over-year revenue increase, surpassing earnings expectations.,Transactions and institutional investments d...
How Is SpringWorks Therapeutics (NASDAQ:SWTX) Expanding Its Biopharmaceutical Pipeline
February 14, 2025 08:21 AM PST| By Team Kalkine MediaHighlights,Financial firms maintain positive ratings for SpringWorks Therapeutics, with price targets reflecting growth expectations.,Company executives have reduced their stock holdings through recent transactions.,Institutional firms have increased...
How Is Patterson Companies (NASDAQ:PDCO) Expanding Its Presence in the Dental and Animal Health Markets
February 14, 2025 08:19 AM PST| By Team Kalkine MediaHighlights,Patterson Companies has received mixed ratings from financial firms, with a one-year target price of $26.57.,The company reported quarterly revenue growth but earnings fell below expectations.,Institutional investors own over 85% of the co...
How Are Institutional Investments Influencing Day One Biopharmaceuticals (NASDAQ:DAWN)
February 14, 2025 08:18 AM PST| By Team Kalkine MediaHighlights,Financial firms predominantly issue a positive rating for Day One Biopharmaceuticals.,Insider transactions, including stock sales by Samuel C. Blackman, have influenced ownership structure.,Institutional investors collectively hold nearly...
How Are Market Ratings Influencing GE HealthCare Technologies (NASDAQ:GEHC)
February 14, 2025 08:18 AM PST| By Team Kalkine MediaHighlights,Stratos Wealth Partners LTD. expanded its stake in GE HealthCare Technologies by nearly 20%.,Institutional investors collectively own over 82% of the company’s stock.,GE HealthCare Technologies increased its quarterly dividend, signaling f...
How Is GE HealthCare Technologies (NASDAQ:GEHC) Strengthening Its Market Position
February 14, 2025 08:16 AM PST| By Team Kalkine MediaHighlights,GE HealthCare Technologies’ stock rose following a strong earnings report.,The company exceeded financial projections and increased its quarterly dividend.,Institutional firms have made strategic adjustments to their holdings in the compan...
How Are Executive Stock Sales Impacting PTC Therapeutics (NASDAQ:PTCT)
February 14, 2025 08:13 AM PST| By Team Kalkine MediaHighlights,Multiple financial firms have adjusted their price targets for PTC Therapeutics, reflecting varied market perspectives.,Executive stock transactions, including sales by Christine Marie Utter and Neil Gregory Almstead, have drawn attention....
How Is Quantum-Si (NASDAQ:QSI) Navigating Market Volatility
February 14, 2025 08:11 AM PST| By Team Kalkine MediaHighlights,Institutional firms, including Sumitomo Mitsui Trust Group Inc., have made notable adjustments to their Quantum-Si holdings.,Quantum-Si’s stock has experienced fluctuations, reflecting broader market activity.,Executive stock sales, includ...
How Are Executive Transactions Impacting Gilead Sciences (NASDAQ:GILD)
February 14, 2025 08:10 AM PST| By Team Kalkine MediaHighlights,Institutional firms hold a significant portion of Gilead Sciences stock.,The company reported earnings that exceeded market expectations.,Recent executive stock transactions reflect ongoing adjustments.,Gilead Sciences,(NASDAQ:GILD),operat...
How Is RxSight (NASDAQ:RXST) Strengthening Its Market Position
February 14, 2025 08:08 AM PST| By Team Kalkine MediaHighlights,Institutional and executive transactions reflect ongoing adjustments in RxSight's stock positions.,The company specializes in light adjustable intraocular lenses, enhancing its presence in the medical device industry.,Market activity indic...
How Is Rallybio (NASDAQ:RLYB) Strengthening Its Market Position
February 14, 2025 08:08 AM PST| By Team Kalkine MediaHighlights,Institutional firms and hedge funds maintain significant holdings in Rallybio.,The company specializes in developing therapies for rare diseases.,Recent stock movements reflect activity in the biotechnology sector.,Rallybio,(NASDAQ:RLYB),o...
Virpax Pharmaceuticals Announces Positive Results from U.S. Army Study on Probudur™
February 13, 2025 09:19 PM PST| By Team Kalkine MediaHighlights,Successful Study Completion:,U.S. Army Institute of Surgical Research (USAISR) completes full study on Probudur™ for post-surgical pain.,Promising Pain Reduction:,Probudur showed a significant reduction in incision-induced pain behaviors i...
How Has Institutional Trading Impacted Pacific Biosciences? (NASDAQ:PACB)
February 13, 2025 09:30 AM PST| By Team Kalkine MediaHighlights,Sumitomo Mitsui Trust Group Inc. reduced its stake in Pacific Biosciences.,The stock fluctuated between $1.16 and $6.83 over the past year.,The company develops genetic sequencing technologies.,Institutional Activity in Pacific Biosciences...
